Combined effects of hypertension and heart rate on the risk of stroke and coronary heart disease: A population-based prospective cohort study among Inner Mongolians in China

Hypertension Research

Volumn 38, Issue 12, 2015, Pages 883-888

  Zhong, Chongke ^a   Zhong, Xiaoyan ^a   Xu, Tian ^a   Peng, Hao ^a   Li, Hongmei ^a   Zhang, Mingzhi ^a   Wang, Aili ^a   Xu, Tan ^a   Sun, Yingxian ^b   Zhang, Yonghong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

cohort study; coronary heart disease; heart rate; stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONGOLIAN (PEOPLE); OUTCOME ASSESSMENT; POPULATION; PROSPECTIVE STUDY; RISK ASSESSMENT; AGED; COMPLICATION; CORONARY ARTERY DISEASE; RISK; STROKE;

ADULT; AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; STROKE;

EID: 84949502966     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.90     Document Type: Article

References (37)

1. Narayan KV, Ali MK, Koplan JP. Global noncommunicable diseases-where worlds meet. N Engl J Med 2010; 363: 1196-1198
2. Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, Wu ZS, Chen WW, Liu MB. Outline of the report on cardiovascular disease in china, 2010. Biomed Environ Sci 2012; 25: 251-256
3. Gaziano T. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 2008; 94: 140-144
4. Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs 2011; 10: S5-S13
5. Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223
7. Cooney MT, Vartiainen E, Laakitainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159: 612-619. e613
8. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR Jr, Hirai Y, Imaizumi T. Heart rate and mortality in a japanese general population: : an18-year follow-up study. J Clin Epidemiol 2001; 54: 495-500
9. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585-592
10. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, De Leeuw PW, Jaaskivi M, Leonetti G, Nachev C. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313-2321
11. Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ontarget/transcend. Clin Res Cardiol 2014; 103: 149-159
12. Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener H-C. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J 2012; 33: 2804-2812
13. Bemelmans RH, van Der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL. The risk of resting heart rate on vascular events and mortality in vascular patients. Int J Cardiol 2013; 168: 1410-1415
14. Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, Pepine CJ. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: Findings from the international verapamil-sr/trandolapril study (invest). Eur Heart J 2008; 29: 1327-1334
15. Morcet J-F, Safar M, Thomas F, Guize L, Benetos A. Associations between heart rate and other risk factors in a large French population. J Hypertens 1999; 17: 1671-1676
16. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population role of age, gender, and blood pressure. Hypertension 1999; 33: 44-52
17. Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J 2008; 72: 1666-1673
18. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
20. Goldstein M, Barnett H, Orgogozo J, Sartorius N, Symon L, Vereshchagin N. Stroke-1989: Recommendations on stroke prevention, diagnosis, and therapy. Report of the who task force on stroke and other cerebrovascular disorders. Stroke 1989; 20: 1407-1431
21. Tuomilehto J, Kuulasmaa K. Who monica project: assessing chd mortality and morbidity. Int J Epidemiol 1988; 18: S38-S45
22. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am 1997; 81: 1077-1097
23. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen C-S, Chen J, Wildman RP. Major causes of death among men and women in china. N Engl J Med 2005; 353: 1124-1134
24. Law M, Morris J, Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Brit Med J 2009; 338: b1665
25. Trialists'Collaboration BPLT. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-1535
26. Palatini P. Elevated heart rate: A new cardiovascular risk factor? Progr Cardiovasc Dis 2009; 52: 1-5
27. Jensen MT, Marott JL, Jensen GB. Elevated resting heart rate is associated with greater risk of cardiovascular and all-cause mortality in current and former smokers. Int J Cardiol 2011; 151: 148-154
28. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (beautiful): a subgroup analysis of a randomised controlled trial. Lancet 2008; 372: 817-821
29. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, De Leeuw PW, Jaaskivi M, Leonetti G, Nachev C, O'Brien ET, Parati G, Rodicio JL, Roman E, Sarti C, Tuomilehto J. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313-2321
30. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The framingham study. Am Heart J 1993; 125: 1148-1154
31. Palatini P. Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease. Curr Hypertens Rep 2001; 3: S3-S9
32. Custodis F, Gertz K, Balkaya M, Prinz V, Mathar I, Stamm C, Kronenberg G, Kazakov A, Freichel M, Böhm M. Heart rate contributes to the vascular effects of chronic mental stress effects on endothelial function and ischemic brain injury in mice. Stroke 2011; 42: 1742-1749
33. Bassiouny HS, Zarins CK, Lee DC, Skelly CL, Fortunato JE, Glagov S. Diurnal heart rate reactivity: A predictor of severity of experimental coronary and carotid atherosclerosis. J Cardiovasc Risk 2002; 9: 331-338
34. Inoue T, Iseki K, Ohya Y. Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease. Hypertens Res 2013; 36: 838-844
35. Elstad M, Walløe L, Chon KH, Toska K. Low-frequency fluctuations in heart rate, cardiac output and mean arterial pressure in humans: What are the physiological relationships? J Hypertens 2011; 29: 1327-1336
36. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3-17
37. Ushigome E, Fukui M, Hamaguchi M, Tanaka T, Atsuta H, Ohnishi M, Tsunoda S, Yamazaki M, Hasegawa G, Nakamura N. Home-measured heart rate is associated with albuminuria in patients with type 2 diabetes mellitus: a post-hoc analysis of a cross-sectional multicenter study. Hypertens Res 2014; 37: 533-537